Sale!

DSP Gene Arrhythmogenic Right Ventricular Cardiomyopathy Type 8 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The DSP Gene Arrhythmogenic Right Ventricular Cardiomyopathy Type 8 Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to detect mutations in the DSP gene, which are associated with Arrhythmogenic Right Ventricular Cardiomyopathy Type 8 (ARVC8). ARVC8 is a form of heart disease that affects the muscle of the right ventricle, leading to arrhythmias and potentially heart failure. This genetic condition is inheritable, making the test particularly valuable for individuals with a family history of ARVC8 or related symptoms.

The test involves analyzing the patient’s DNA to identify any genetic variations in the DSP gene that could indicate a predisposition to developing ARVC8. Early detection through this genetic test can be crucial for managing the condition, allowing for tailored treatment plans and lifestyle adjustments to mitigate the risk of severe cardiac events.

The cost of the DSP Gene Arrhythmogenic Right Ventricular Cardiomyopathy Type 8 Genetic Test at DNA Labs UAE is 4400 AED. Given the specialized nature of this test and its potential to significantly impact patient care, the investment can be considered valuable for those at risk. DNA Labs UAE provides this testing service with professionalism and confidentiality, ensuring that patients receive accurate and helpful genetic insights into their cardiac health.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

DSP Gene Arrhythmogenic right ventricular cardiomyopathy type 8 Genetic Test

Welcome to DNA Labs UAE, where we offer the DSP Gene Arrhythmogenic right ventricular cardiomyopathy type 8 Genetic Test. This test is designed to diagnose and manage individuals suspected of having ARVC type 8, a genetic disorder that affects the heart muscle.

Test Components and Price

  • Components: NGS Technology
  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks

Test Type and Doctor

The DSP Gene Arrhythmogenic right ventricular cardiomyopathy type 8 Genetic Test falls under the category of Cardiovascular Pneumology Disorders. It is recommended to consult a Cardiologist for this test.

Test Department and Pre Test Information

The test is conducted in our Genetics department. Before undergoing the DSP Gene Arrhythmogenic right ventricular cardiomyopathy type 8 NGS Genetic DNA Test, it is essential to provide the clinical history of the patient. Additionally, a Genetic Counselling session will be conducted to draw a pedigree chart of family members affected by ARVC type 8.

Understanding ARVC

Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a genetic disorder that primarily affects the right ventricle of the heart. This condition is characterized by the replacement of normal heart muscle with fatty or fibrous tissue, leading to abnormal heart rhythms and potentially life-threatening arrhythmias.

About NGS Genetic Testing

Next-Generation Sequencing (NGS) genetic testing is a diagnostic tool used to identify genetic mutations associated with various diseases, including ARVC. It involves sequencing the DNA of an individual to identify specific genetic variants or mutations that may be causing the condition.

The Role of the DSP Gene

The DSP (Desmoplakin) gene has been associated with ARVC, particularly ARVC type 8. Mutations in the DSP gene can disrupt the normal function of desmoplakin, a protein responsible for maintaining the structural integrity of heart muscle cells. This disruption can lead to the development of ARVC type 8.

About the DSP Gene Arrhythmogenic right ventricular cardiomyopathy type 8 NGS Genetic Test

The DSP Gene Arrhythmogenic right ventricular cardiomyopathy type 8 NGS Genetic Test utilizes NGS technology to analyze the DSP gene for mutations or variants that may be associated with ARVC type 8. This test aids in the diagnosis and management of individuals suspected of having ARVC.

For more information or to schedule a test, please contact our Genetic department.

Test Name DSP Gene Arrhythmogenic right ventricular cardiomyopathy type 8 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Cardiovascular Pneumology Disorders
Doctor Cardiologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for DSP Gene Arrhythmogenic right ventricular cardiomyopathy type 8 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with DSP Gene Arrhythmogenic right ventricular cardiomyopathy type 8 NGS Genetic DNA Test gene DSP
Test Details

Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a genetic disorder that affects the heart muscle, particularly the right ventricle. It is characterized by the replacement of normal heart muscle with fatty or fibrous tissue, leading to abnormal heart rhythms and potentially life-threatening arrhythmias.

NGS (Next-Generation Sequencing) genetic testing is a diagnostic tool used to identify genetic mutations associated with various diseases, including ARVC. It involves sequencing the DNA of an individual to identify any specific genetic variants or mutations that may be causing the condition.

DSP (Desmoplakin) is a gene that has been associated with ARVC, specifically ARVC type 8. Mutations in the DSP gene can disrupt the normal function of desmoplakin, a protein involved in maintaining the structural integrity of heart muscle cells. This disruption can lead to the development of ARVC.

Therefore, the “DSP Gene Arrhythmogenic right ventricular cardiomyopathy type 8 NGS Genetic Test” refers to a genetic test that uses NGS technology to analyze the DSP gene for mutations or variants that may be associated with ARVC type 8. This test can help in the diagnosis and management of individuals suspected of having ARVC.